A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Synovial Biopsy Study of JNJ-38518168 in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Phase of Trial: Phase II
Latest Information Update: 15 Jul 2015
At a glance
- Drugs Toreforant (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Biomarker; Pharmacodynamics
- Sponsors Janssen Research & Development
- 31 Jul 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 08 May 2014 Planned number of patients changed from 24 to 25 as reported by ClinicalTrials.gov.
- 12 Aug 2013 Actual initiation date changed from May 2013 to Jul 2013, as reported by ClinicalTrials.gov.